Cardiology

In commemoration of Wear Red Day, here's a breakdown of how US regions differ in cardiovascular disease burden among women.

Knowing the symptoms and risk factors of CVD unique to women can aid in awareness and prevention efforts.

Dr. Poornima explores improving engagement in women’s cardiovascular care from both a provider and a patient level.

Cardiovascular disease is the leading cause of death for women.

Released on February 4, the latest expert consensus statement from the Society for Cardiovascular Angiography and Interventions provides clinicians with an overview of available knowledge related to myocardial revascularization in women and calls attention to existing gaps in knowledge.

Women with high social isolation and high loneliness scores had a 13.0% - 27.0% higher risk of incident CVD compared to women with low scores.

Dr. Radhakrishnan discusses both the effects of gender bias and why women don't get screened for heart disease.

On Wear Red Day, Dr. Ivanova advocates for increased awareness and diversity in women's cardiovascular care.

Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.

Released on Jan. 31, the updated consensus statement from the Society for Cardiovascular Angiography and Interventions provides a 3-axis model for shock classification and represents the first update since the original statement was released in 2019.

Rates of aspirin use for preeclampsia prophylaxis were observed in a minority of women with risk factors including pre-pregnancy diabetes, obesity, or chronic hypertension.

Don't Miss a Beat is Practical Cardiology's expert-led podcast. The monthly podcast, which is hosted by Drs. Greene and Vaduganathan, will provide a regular news roundup of the latest evidence and clinical trial insights across cardiovascular, renal, and metabolic diseases.

Each month, our editorial staff compiles a month in review highlighting the most popular content from the past month. January's month in review features new guidelines, a panel discussion, COVID-19-related news, and more.

Dr. Gregory Weiss provides insight into what he is most excited about in the field of cardiovascular medicine heading into 2022.

There was not an association between sleep duration and metabolic diseases found in men.

An analysis of Vaccine Adverse Event Reporting System (VAERS) data suggests three-fourths of all myocarditis cases observed in the first 8 months of COVID-19 vaccination occurred in persons 30 years and younger.

New findings from CDC data show three-fourths of all myocarditis cases observed in the first 8 months of COVID-19 vaccination occurred in persons 30 years and younger.

The new guidelines conclude that current evidence is insufficient to assess the balance of benefits and harms of screening for AF in adults ≥50 years.

On January 25, the Society of Thoracic Surgeons and American Association of Thoracic Surgery released new guideline recommendations for the diagnosis and management of patients with type B aortic dissection.

Our latest case report from Brady Pregerson, MD, features a woman in her mid-70’s presenting with a head injury and reports having a swollen leg for a few days 3 weeks ago that has since resolved. Can you determine the correct diagnosis?

Early-pregnancy NT-proBNP level may be an important determinant of pregnancy outcomes and CV risk.

New data suggests higher concentrations of NT-proBNP in early pregnancy could help predict women at a lower risk for developing hypertensive disorders of pregnancy and future hypertension.

A comparative effectiveness study of Medicare claims data suggests gastric bypass surgery was associated with a greater rate of discontinuation of medications for obesity-related comorbidities than sleeve gastrectomy.

On January 20, the AHA released a presidential advisory to raise awareness and provide risk mitigation strategies to prevent death from vasovagal compromise following BPG use in patients with rheumatic heart disease.